NU MED

Nu-Med Plus is a U.S.-listed medical device company focused on nitric oxide generation and delivery technologies for therapeutic and research use. The company is developing a family of inhaled nitric oxide systems, including hospital bedside, portable/mobile, clinical, and research units designed to deliver precision doses of nitric oxide from compressed gas sources. Its development efforts have been aimed at neonatal respiratory care as well as broader applications in pulmonary, cardiovascular, and wound-care settings. Public company profiles and company disclosures describe additional exploratory interest in COPD, ARDS, tuberculosis, malaria, and wound-healing applications. The company appears to be a very small, early-stage healthcare device developer rather than a commercial-stage biotech or pharma company.